“Phase II Study of Irinotecan in Combination With Capecitabine on a 3-Weekly Schedule As First-Line Chemotherapy for Patients With Metastatic or Locally Advanced Colorectal Cancer”. Journal of Analytical Oncology, vol. 2, no. 3, Aug. 2013, pp.  151-159, https://doi.org/10.6000/1927-7229.2013.02.03.4.